Hemangiomas in the face and extremities: MR-guided sclerotherapy--optimization with monitoring of signal intensity changes in vivo

Radiology. 2003 Feb;226(2):567-72. doi: 10.1148/radiol.2262012157.


The feasibility of a method of magnetic resonance (MR)-guided sclerotherapy for hemangioma was evaluated. The distribution of a test injection and a contiguous sclerosant injection was monitored clearly with MR fluoroscopy. Postsclerotherapy T2-weighted MR images depicted areas with and those without effective sclerosant concentration, which enabled performance of selective supplemental sclerotherapy. This method of MR-guided sclerotherapy seems feasible for clinical application.

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Contrast Media / administration & dosage
  • Extremities
  • Facial Neoplasms / therapy*
  • Feasibility Studies
  • Female
  • Gadolinium DTPA / administration & dosage
  • Hemangioma / therapy*
  • Humans
  • Magnetic Resonance Imaging*
  • Male
  • Sclerosing Solutions / administration & dosage
  • Sclerotherapy*
  • Soft Tissue Neoplasms / therapy*
  • Treatment Outcome


  • Contrast Media
  • Sclerosing Solutions
  • Gadolinium DTPA